Indivior Pharmaceuticals Inc (INDV) Stock Overview
Explore Indivior Pharmaceuticals Inc’s financial performance, market position, analyst ratings, and future outlook.
Indivior Pharmaceuticals Inc (INDV)
Key Financials
Key Financials
Market Cap
4.8B
P/E Ratio
13.42
EPS (TTM)
$3.65
ROE
-2.16%
INDV Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Indivior Pharmaceuticals Inc (NASDAQ: INDV) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Indivior Pharmaceuticals Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of INDV on the NASDAQ shows an RSI of 48.58, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $42.79 for the NASDAQ listing.
Key metrics behind Indivior Pharmaceuticals Inc's NASDAQ-traded stock include a P/E ratio of 13.42 and a market capitalization of 4.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of INDV on the NASDAQ.